{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fasiglifam", "query": { "intervention": "Fasiglifam" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 12, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fasiglifam&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T06:05:14.749Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01982253", "title": "Fasiglifam 25 mg BID vs 50 mg QD", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Fasiglifam", "type": "DRUG" }, { "name": "Placebo to fasiglifam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2013-10", "completion_date": "2014-01", "has_results": true, "last_update_posted_date": "2016-10-07", "last_synced_at": "2026-09-02T06:05:14.749Z", "location_count": 47, "location_summary": "Goodyear, Arizona • Long Beach, California • Los Angeles, California + 44 more", "locations": [ { "city": "Goodyear", "state": "Arizona" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "North Hollywood", "state": "California" }, { "city": "Norwalk", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01982253" }, { "nct_id": "NCT01609582", "title": "Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes", "Cardiovascular Disease" ], "interventions": [ { "name": "TAK-875", "type": "DRUG" }, { "name": "TAK-875 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3207, "start_date": "2012-06", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2015-10-19", "last_synced_at": "2026-09-02T06:05:14.749Z", "location_count": 218, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Mobile, Alabama + 215 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Pell City", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01609582" }, { "nct_id": "NCT01829477", "title": "Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "TAK-875", "type": "DRUG" }, { "name": "TAK-875 Placebo", "type": "DRUG" }, { "name": "Glimepiride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2013-04", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2016-06-01", "last_synced_at": "2026-09-02T06:05:14.749Z", "location_count": 38, "location_summary": "Muscle Shoals, Alabama • Phoenix, Arizona • Fresno, California + 35 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "National City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01829477" }, { "nct_id": "NCT01414920", "title": "Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "TAK-875", "type": "DRUG" }, { "name": "Sitagliptin", "type": "DRUG" }, { "name": "TAK-875 and Sitagliptin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 368, "start_date": "2011-08", "completion_date": "2012-08", "has_results": false, "last_update_posted_date": "2016-04-04", "last_synced_at": "2026-09-02T06:05:14.749Z", "location_count": 80, "location_summary": "Birmingham, Alabama • Brimingham, Alabama • Chandler, Arizona + 77 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Brimingham", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Green Valley", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01414920" }, { "nct_id": "NCT01456195", "title": "Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Fasiglifam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 421, "start_date": "2011-11", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2016-04-05", "last_synced_at": "2026-09-02T06:05:14.749Z", "location_count": 55, "location_summary": "Dothan, Alabama • Muscle Shoals, Alabama • Goodyear, Arizona + 52 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01456195" }, { "nct_id": "NCT01549964", "title": "Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glycemic Control" ], "interventions": [ { "name": "Fasiglifam (TAK-875)", "type": "DRUG" }, { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 916, "start_date": "2012-04", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2016-06-02", "last_synced_at": "2026-09-02T06:05:14.749Z", "location_count": 58, "location_summary": "Muscle Shoals, Alabama • Mesa, Arizona • Peoria, Arizona + 55 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01549964" }, { "nct_id": "NCT01007097", "title": "Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "TAK-875", "type": "DRUG" }, { "name": "Glimepiride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 426, "start_date": "2009-12", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2016-04-13", "last_synced_at": "2026-09-02T06:05:14.749Z", "location_count": 64, "location_summary": "Birmingham, Alabama • Hoover, Alabama • Tucson, Arizona + 61 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Burlingame", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01007097" }, { "nct_id": "NCT01829464", "title": "TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "TAK-875", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2013-05", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2016-06-01", "last_synced_at": "2026-09-02T06:05:14.749Z", "location_count": 82, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Muscle Shoals, Alabama + 78 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01829464" }, { "nct_id": "NCT01496443", "title": "TAK-875 Glimepiride Drug-Interaction Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pharmacokinetics" ], "interventions": [ { "name": "TAK-875 and Glimepiride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "68 Years", "sex": "ALL", "summary": "18 Years to 68 Years" }, "enrollment_count": 28, "start_date": "2012-01", "completion_date": "2012-05", "has_results": false, "last_update_posted_date": "2012-09-13", "last_synced_at": "2026-09-02T06:05:14.749Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01496443" }, { "nct_id": "NCT02015780", "title": "Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus", "Chronic Kidney Disease" ], "interventions": [ { "name": "Fasiglifam", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Antihyperglycemic therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2013-12", "completion_date": "2016-01", "has_results": false, "last_update_posted_date": "2014-01-27", "last_synced_at": "2026-09-02T06:05:14.749Z", "location_count": 7, "location_summary": "Whittier, California • Westminster, Colorado • Tampa, Florida + 4 more", "locations": [ { "city": "Whittier", "state": "California" }, { "city": "Westminster", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Rosedale", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02015780" } ] }